Breaking Down the Avascular Necrosis Market – Key Insights & Forecasts

The Global Avascular Necrosis Market Size accounted for USD 671 Million in 2023 and is estimated to achieve a market size of USD 1,178.1 Million by 2032 growing at a CAGR of 6.6% from 2024 to 2032.
By: Acumen Research
 
ARKADELPHIA, Ark. - April 22, 2025 - PRLog -- Introduction:

The Avascular Necrosis (AVN) Market is witnessing significant growth due to increasing prevalence, advancements in diagnostic techniques, and rising demand for effective treatment options. Avascular necrosis, also known as osteonecrosis, occurs when bone tissue dies due to a lack of blood supply, commonly affecting the hip, knee, shoulder, and other joints. The condition can lead to severe pain, joint collapse, and disability if left untreated.

Market Overview and Growth Drivers

The global avascular necrosis market is projected to expand at a steady CAGR (Compound Annual Growth Rate) over the forecast period (2023-2030). Key factors driving market growth include:

1. Rising Prevalence of AVN
  • Increasing cases due to trauma, steroid use, alcoholism, and chronic diseases like diabetes and lupus.
  • Growing elderly population, which is more susceptible to bone-related disorders.
2. Advancements in Diagnostic Technologies
  • Improved imaging techniques such as MRI, CT scans, and X-rays enable early detection.
  • Development of biomarkers for early diagnosis to prevent disease progression.
Click here for more details: https://www.globenewswire.com/news-release/2022/08/10/2495734/0/en/Avascular-Necrosis-Market-Size-is-predicted-to-reach-at-USD-1-026-Million-by-2030-registering-a-CAGR-of-6-1-Owing-to-Increasing-Number-of-Medicines-Approvals-from-Regulatory-Agenci.html?f=22&fvtc=5&fvtv=37025363

3. Increasing Demand for Minimally Invasive Treatments
  • Rising preference for core decompression, stem cell therapy, and bone grafting over traditional surgical methods.
  • Growth in arthroplasty (joint replacement) procedures for advanced AVN cases.
4. Expanding Biopharmaceutical Research
  • Clinical trials focusing on bone regeneration drugs and biologics to slow AVN progression.
  • Emerging therapies such as BMP (Bone Morphogenetic Proteins) and bisphosphonates showing promising results.
Challenges in the Avascular Necrosis Market

Despite growth prospects, the market faces certain hurdles:
  • High treatment costs of surgical procedures like joint replacements.
  • Limited awareness in developing regions leading to delayed diagnosis.
  • Side effects of long-term medication use, such as bisphosphonate-related complications.
Future Outlook and Opportunities

The AVN market is poised for expansion with:
  • Development of novel regenerative medicines to restore bone health.
  • Increased adoption of robotic-assisted surgeries for precision in joint replacements.
  • Government initiatives supporting AVN research and patient care programs.
View source for more information: https://www.acumenresearchandconsulting.com/avascular-necrosis-market

Media Contact
Prashant
***@acumenresearchandconsulting.com
+918983225533
End
Source:Acumen Research
Email:***@acumenresearchandconsulting.com Email Verified
Tags:Marketreserach
Industry:Health
Location:Arkadelphia - Arkansas - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Acumen Research and Consulting PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share